CAMP

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

CAMP4 THERAPEUTICS CORPORATION

NASDAQ | CAMP

4.25

USD

$0.00

(

0.00%

)

At Close (As of Nov 7, 2025)

$89.72M

Market Cap

-

P/E Ratio

-2.57

EPS

$12.26

52 Week High

$1.30

52 Week Low

HEALTHCARE

Sector

CAMP Chart

Recent Chart
Price Action

CAMP Technicals

Tags:

CAMP Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $652K
Total Revenue $652K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$53M
Selling General And Administrative $15M
Research And Development $39M
Operating Expenses $54M
Investment Income Net -
Net Interest Income $1.3M
Interest Income $1.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$52M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$52M
Comprehensive Income Net Of Tax -
Ebit -$53M
Ebitda -$51M
Net Income -$52M

Revenue & Profitability

Earnings Performance

CAMP Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $78M
Total Current Assets $66M
Cash And Cash Equivalents At Carrying Value $64M
Cash And Short Term Investments $64M
Inventory -
Current Net Receivables $108K
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $2.2M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $9.6M
Current Accounts Payable $1.2M
Deferred Revenue -
Current Debt -
Short Term Debt $3.1M
Total Non Current Liabilities $5.6M
Capital Lease Obligations $8.6M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $8.6M
Other Current Liabilities $1.7M
Other Non Current Liabilities $2K
Total Shareholder Equity $63M
Treasury Stock -
Retained Earnings -$212M
Common Stock $2K
Common Stock Shares Outstanding $20M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$46M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.7M
Capital Expenditures $441K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$441K
Cashflow From Financing $72M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$52M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $652K
Total Revenue $652K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$53M
Selling General And Administrative $15M
Research And Development $39M
Operating Expenses $54M
Investment Income Net -
Net Interest Income $1.3M
Interest Income $1.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.7M
Income Before Tax -$52M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$52M
Comprehensive Income Net Of Tax -
Ebit -$53M
Ebitda -$51M
Net Income -$52M

CAMP News

CAMP Profile

CAMP4 THERAPEUTICS CORPORATION Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

CAMP4 Therapeutics Corporation, based in Irvine, California, is an innovative biotechnology firm at the forefront of gene regulation and therapeutic development aimed at addressing complex and currently untreatable diseases. Utilizing its proprietary platform technology, the company focuses on creating breakthrough therapies that target the root causes of conditions, offering hope for improved patient outcomes. With a strong emphasis on scientific advancement and strategic collaborations, CAMP4 is well-positioned to become a leader in the genetic medicine landscape, paving the way for transformative healthcare solutions.

BKYI
+51.56%
$0.96
RUBI
+39.37%
$0.31
AZI
-4.05%
$0.09
NVDA
+0.03%
$188.15
ASST
+4.13%
$1.51
ACHR
-7.88%
$8.18
BYND
+16.80%
$1.39
PFE
+0.04%
$24.43
PLUG
+5.57%
$2.65
ONDS
+10.66%
$5.81
MSGM
+70.77%
$3.74
TSLA
-3.67%
$429.52
INTC
+2.38%
$38.13
VHAI
0.00%
$0.00
GRAB
-1.24%
$5.56
F
+1.82%
$13.21
SOFI
+3.86%
$28.21
DNN
-0.39%
$2.54
PLTR
+1.64%
$177.93
WTO
-7.52%
$0.04
BITF
-0.81%
$3.66
SNAP
+2.49%
$8.21
AAL
+3.80%
$13.65
AXDX
-61.36%
$0.03
NIO
-4.18%
$6.86
RIVN
+0.06%
$15.23
CHR
+0.15%
$0.06
DVLT
+24.26%
$1.69
T
+0.36%
$24.83
ETHD
-9.69%
$4.38
RGTI
-1.71%
$33.77
BURU
+3.54%
$0.28
BTG
+2.89%
$3.91
PBR
+5.93%
$12.86
IREN
-6.83%
$62.38
JOBY
+4.05%
$14.90
RXRX
0.00%
$4.62
PRMB
-18.30%
$14.46
AMD
-1.75%
$233.54
MARA
-0.56%
$15.87
ADAP
-15.14%
$0.05
QBTS
+3.90%
$29.50
SOUN
-0.63%
$14.14
IONZ
-6.57%
$3.55
YDKG
-1.56%
$0.05
NVTS
-11.26%
$7.84
AAPL
-0.48%
$268.47
KVUE
+2.55%
$16.88
AMZN
+0.56%
$244.41
BMNR
+7.65%
$40.22
CIFR
-4.69%
$20.69
HOOD
+2.58%
$130.36
MTVA
+6.84%
$0.90
WULF
-2.38%
$13.94
SMR
-6.53%
$30.34
BTBT
+3.63%
$3.14
DKNG
+8.64%
$30.40
EOSE
+19.42%
$18.26
NOK
-1.01%
$6.84
BAC
-0.16%
$53.20
RMBL
+60.50%
$3.21
ABEV
+1.25%
$2.43
RIG
+2.05%
$3.98
ADD
-25.47%
$0.05
TLRY
+2.47%
$1.24
VIVK
+11.85%
$0.16
GPUS
+0.43%
$0.37
SRM
+53.27%
$10.30
GOOGL
-2.07%
$278.83
TTD
-6.31%
$43.00
CMG
+0.09%
$30.59
QS
+4.52%
$16.62
ORGO
+44.73%
$5.63
SMCI
-1.42%
$39.76
IONQ
+3.20%
$59.27
PLTZ
-3.51%
$6.86
FIG
-3.76%
$44.25
EPWK
+3.23%
$0.07
VALE
-0.65%
$12.15
WBD
+1.11%
$22.67
MU
-0.17%
$237.92
AMC
-7.30%
$2.41
RF
+2.22%
$24.85
META
+0.44%
$621.71
MTC
-6.85%
$2.58
PTON
+14.15%
$7.66
ELDN
-49.75%
$2.06
IOVA
-0.43%
$2.29
CGC
+7.33%
$1.17
HIMS
-1.18%
$41.03
WLGS
-5.57%
$0.04
CAN
+5.30%
$1.19
VZ
+0.52%
$40.03
BBD
+0.85%
$3.54
HBAN
+1.75%
$15.69
QUBT
-2.20%
$12.86
NGD
+1.58%
$7.03
CLSK
+1.10%
$15.57
ETWO
0.00%
$3.30
AMCR
+1.82%
$8.36
BKYI
+51.56%
$0.96
RUBI
+39.37%
$0.31
AZI
-4.05%
$0.09
NVDA
+0.03%
$188.15
ASST
+4.13%
$1.51
ACHR
-7.88%
$8.18
BYND
+16.80%
$1.39
PFE
+0.04%
$24.43
PLUG
+5.57%
$2.65
ONDS
+10.66%
$5.81
MSGM
+70.77%
$3.74
TSLA
-3.67%
$429.52
INTC
+2.38%
$38.13
VHAI
0.00%
$0.00
GRAB
-1.24%
$5.56
F
+1.82%
$13.21
SOFI
+3.86%
$28.21
DNN
-0.39%
$2.54
PLTR
+1.64%
$177.93
WTO
-7.52%
$0.04
BITF
-0.81%
$3.66
SNAP
+2.49%
$8.21
AAL
+3.80%
$13.65
AXDX
-61.36%
$0.03
NIO
-4.18%
$6.86
RIVN
+0.06%
$15.23
CHR
+0.15%
$0.06
DVLT
+24.26%
$1.69
T
+0.36%
$24.83
ETHD
-9.69%
$4.38
RGTI
-1.71%
$33.77
BURU
+3.54%
$0.28
BTG
+2.89%
$3.91
PBR
+5.93%
$12.86
IREN
-6.83%
$62.38
JOBY
+4.05%
$14.90
RXRX
0.00%
$4.62
PRMB
-18.30%
$14.46
AMD
-1.75%
$233.54
MARA
-0.56%
$15.87
ADAP
-15.14%
$0.05
QBTS
+3.90%
$29.50
SOUN
-0.63%
$14.14
IONZ
-6.57%
$3.55
YDKG
-1.56%
$0.05
NVTS
-11.26%
$7.84
AAPL
-0.48%
$268.47
KVUE
+2.55%
$16.88
AMZN
+0.56%
$244.41
BMNR
+7.65%
$40.22
CIFR
-4.69%
$20.69
HOOD
+2.58%
$130.36
MTVA
+6.84%
$0.90
WULF
-2.38%
$13.94
SMR
-6.53%
$30.34
BTBT
+3.63%
$3.14
DKNG
+8.64%
$30.40
EOSE
+19.42%
$18.26
NOK
-1.01%
$6.84
BAC
-0.16%
$53.20
RMBL
+60.50%
$3.21
ABEV
+1.25%
$2.43
RIG
+2.05%
$3.98
ADD
-25.47%
$0.05
TLRY
+2.47%
$1.24
VIVK
+11.85%
$0.16
GPUS
+0.43%
$0.37
SRM
+53.27%
$10.30
GOOGL
-2.07%
$278.83
TTD
-6.31%
$43.00
CMG
+0.09%
$30.59
QS
+4.52%
$16.62
ORGO
+44.73%
$5.63
SMCI
-1.42%
$39.76
IONQ
+3.20%
$59.27
PLTZ
-3.51%
$6.86
FIG
-3.76%
$44.25
EPWK
+3.23%
$0.07
VALE
-0.65%
$12.15
WBD
+1.11%
$22.67
MU
-0.17%
$237.92
AMC
-7.30%
$2.41
RF
+2.22%
$24.85
META
+0.44%
$621.71
MTC
-6.85%
$2.58
PTON
+14.15%
$7.66
ELDN
-49.75%
$2.06
IOVA
-0.43%
$2.29
CGC
+7.33%
$1.17
HIMS
-1.18%
$41.03
WLGS
-5.57%
$0.04
CAN
+5.30%
$1.19
VZ
+0.52%
$40.03
BBD
+0.85%
$3.54
HBAN
+1.75%
$15.69
QUBT
-2.20%
$12.86
NGD
+1.58%
$7.03
CLSK
+1.10%
$15.57
ETWO
0.00%
$3.30
AMCR
+1.82%
$8.36
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.